0001193125-26-395734.txt : 20260918 0001193125-26-395734.hdr.sgml : 20260918 20260918172342 ACCESSION NUMBER: 0001193125-26-395734 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260918 DATE AS OF CHANGE: 20260918 EFFECTIVENESS DATE: 20260918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CERENOME, INC. CENTRAL INDEX KEY: 0001095981 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 330827593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598173 FILM NUMBER: 261391783 BUSINESS ADDRESS: STREET 1: 6420 LEVIT GREEN BOULEVARD STREET 2: SUITE 310 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 737.255.7194 MAIL ADDRESS: STREET 1: 6420 LEVIT GREEN BOULEVARD STREET 2: SUITE 310 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: PLUS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20190802 FORMER COMPANY: FORMER CONFORMED NAME: CYTORI THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050712 FORMER COMPANY: FORMER CONFORMED NAME: MACROPORE INC DATE OF NAME CHANGE: 20010320 D 1 primary_doc.xml X0708 D LIVE 0001095981 CERENOME, INC. 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 (737) 255-7194 DELAWARE Plus Therapeutics, Inc. PLUS THERAPEUTICS, INC. CYTORI THERAPEUTICS, INC. MACROPORE INC Corporation true Marc H. Hedrick 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 Executive Officer Director President and Chief Executive Officer Andrew Sims 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 Executive Officer Chief Financial Officer Howard Clowes 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 Director An van Es-Johansson 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 Director Richard J. Hawkins 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 Director Chairman of the Board Ronald A. Andrews 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 Director Kyle Guse 6420 Levit Green Boulevard Suite 310 Houston TX TEXAS 77021 Director Other Health Care Decline to Disclose 06b false 2026-09-10 true true true true false 0 20000000 3000000 17000000 The Company agreed to issue senior secured convertible notes in the aggregate original principal amount of up to $21,276,596, and each of the notes, when issued, reflects an original issue discount of 6.0%. false 1 0 0 0 false CERENOME, INC. /s/ Andrew Sims Andrew Sims Chief Financial Officer 2026-09-18